» Articles » PMID: 11870161

Mutations of HMLH1 and HMSH2 in Patients with Suspected Hereditary Nonpolyposis Colorectal Cancer: Correlation with Microsatellite Instability and Abnormalities of Mismatch Repair Protein Expression

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2002 Mar 1
PMID 11870161
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The relationship between germ-line mutations of hMSH2 and hMLH1, microsatellite instability (MSI), and loss of DNA mismatch repair (MMR) gene expression were studied to formulate an effective selection protocol for patients with suspected hereditary nonpolyposis colorectal cancer who should be offered genetic testing.

Patients And Methods: Patients eligible for germ-line analysis of hMLH1 and hMSH2 were selected. Tumor specimens were obtained to assess MSI and loss of MMR gene expression.

Results: Among 37 patients who participated in the study, two hMSH2 and two hMLH1 missense mutations (11%) were detected, none of which was found in a panel of 60 healthy volunteers. High MSI was found in five tumors (19%) and low MSI in 10 tumors (39%); 12 tumors (46%) were microsatellite stable. Four tumors demonstrated loss of hMLH1, and three tumors demonstrated loss of hMSH2 protein expression.

Conclusion: No relationship was found between MMR gene mutations and MSI; low or no MSI was found in the four patients with germ-line mutations, and none of the five patients with high MSI demonstrated abnormalities of MMR genes. On the contrary, loss of hMLH1 or hMSH2 expression was found in the tumors from three of the four patients demonstrating germ-line mutations. These data suggest that germ-line mutations of the MMR gene can occur in people with MSI-negative tumors. Sensitive clinical criteria and the study of MMR gene expression may be useful to identify this subset of patients.

Citing Articles

Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.

Maccaroni E, Lenci E, Agostinelli V, Cognigni V, Giampieri R, Mazzanti P Explor Target Antitumor Ther. 2022; 2(3):240-248.

PMID: 36046437 PMC: 9400785. DOI: 10.37349/etat.2021.00044.


A germline missense mutation in exon 3 of the MSH2 gene in a Lynch syndrome family: correlation with phenotype and localization assay.

Bianchi F, Maccaroni E, Belvederesi L, Brugiati C, Giampieri R, Bini F Fam Cancer. 2017; 17(2):215-224.

PMID: 28785832 DOI: 10.1007/s10689-017-0030-x.


Predicting the impact of Lynch syndrome-causing missense mutations from structural calculations.

Nielsen S, Stein A, Dinitzen A, Papaleo E, Tatham M, Poulsen E PLoS Genet. 2017; 13(4):e1006739.

PMID: 28422960 PMC: 5415204. DOI: 10.1371/journal.pgen.1006739.


Prognostic impact of mismatch repair genes germline defects in colorectal cancer patients: are all mutations equal?.

Maccaroni E, Bracci R, Giampieri R, Bianchi F, Belvederesi L, Brugiati C Oncotarget. 2015; 6(36):38737-48.

PMID: 26485756 PMC: 4770733. DOI: 10.18632/oncotarget.5395.


Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer.

Vilar E, Mork M, Cuddy A, Borras E, Bannon S, Taggart M Cancer Genet. 2014; 207(10-12):495-502.

PMID: 25432668 PMC: 4278939. DOI: 10.1016/j.cancergen.2014.10.002.